Action required: Please refresh your browser
We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.
More details about this topic are available here »
G1 Therapeutics to Participate in the TD Cowen 44th Annual Health Care Conference | ||
By: GlobeNewswire - 27 Feb 2024 | Back to overview list |
|
RESEARCH TRIANGLE PARK, N.C., Feb. 27, 2024 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (Nasdaq: GTHX), a commercial-stage oncology company, today announced that G1’s Chief Executive Officer Jack Bailey will participate in a Breast & Lung Cancer Corporate Panel Discussion during the TD Cowen 44th Annual Health Care Conference on Wednesday March 6, 2024 at 9:10 AM EST. The webcast of the event will be accessible on the Events & Presentations page of http://www.g1therapeutics.com. About G1 Therapeutics G1 Therapeutics® and the G1 Therapeutics logo and COSELA® and the COSELA logo are trademarks of G1 Therapeutics, Inc. Contacts: |
||
|
||
Copyright 2024 GlobeNewswire | Back to overview list |